 | • レポートコード：GIR-2104Z07252 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ヒト絨毛性ゴナドトロピン（HCG）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヒト絨毛性ゴナドトロピン（HCG）の種類別市場規模（天然源抽出、組換えDNA技術）、用途別市場規模（女性不妊治療、乏精子症治療、停留精巣治療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ヒト絨毛性ゴナドトロピン（HCG）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：EMD Serono, Inc、Ferring B.V、Merck & Co., Inc、Bristol Myers Squibb Company、Fresenius Kabi AG, LLC、Scrippslabs、Leebio、Kamiya Biomedical Company、Sanzyme、Cigna ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：天然源抽出、組換えDNA技術 ・用途別分析2016年-2026年：女性不妊治療、乏精子症治療、停留精巣治療、その他 ・ヒト絨毛性ゴナドトロピン（HCG）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヒト絨毛性ゴナドトロピン（HCG）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヒト絨毛性ゴナドトロピン（HCG）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヒト絨毛性ゴナドトロピン（HCG）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヒト絨毛性ゴナドトロピン（HCG）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Human Chorionic Gonadotropin (HCG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Human Chorionic Gonadotropin (HCG) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Human Chorionic Gonadotropin (HCG) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Human Chorionic Gonadotropin (HCG) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Natural Source Extraction
Recombinant DNA Technology
Market segment by Application can be divided into
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others
The key market players for global Human Chorionic Gonadotropin (HCG) market are listed below:
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG, LLC
Scrippslabs
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Human Chorionic Gonadotropin (HCG) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Chorionic Gonadotropin (HCG) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Natural Source Extraction
1.2.3 Recombinant DNA Technology
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Chorionic Gonadotropin (HCG) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Female Infertility Treatment
1.3.3 Oligospermic Treatment
1.3.4 Cryptorchidism Treatment
1.3.5 Others
1.4 Global Human Chorionic Gonadotropin (HCG) Market Size & Forecast
1.4.1 Global Human Chorionic Gonadotropin (HCG) Sales in Value (2016-2026))
1.4.2 Global Human Chorionic Gonadotropin (HCG) Sales in Volume (2016-2026)
1.4.3 Global Human Chorionic Gonadotropin (HCG) Price by Type (2016-2026) & (USD/Unit)
1.5 Global Human Chorionic Gonadotropin (HCG) Production Capacity Analysis
1.5.1 Global Human Chorionic Gonadotropin (HCG) Total Production Capacity (2016-2026)
1.5.2 Global Human Chorionic Gonadotropin (HCG) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Chorionic Gonadotropin (HCG) Market Drivers
1.6.2 Human Chorionic Gonadotropin (HCG) Market Restraints
1.6.3 Human Chorionic Gonadotropin (HCG) Trends Analysis
2 Manufacturers Profiles
2.1 EMD Serono, Inc
2.1.1 EMD Serono, Inc Details
2.1.2 EMD Serono, Inc Major Business
2.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product and Services
2.1.4 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Ferring B.V
2.2.1 Ferring B.V Details
2.2.2 Ferring B.V Major Business
2.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Product and Services
2.2.4 Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Merck & Co., Inc
2.3.1 Merck & Co., Inc Details
2.3.2 Merck & Co., Inc Major Business
2.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product and Services
2.3.4 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Bristol Myers Squibb Company
2.4.1 Bristol Myers Squibb Company Details
2.4.2 Bristol Myers Squibb Company Major Business
2.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product and Services
2.4.4 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Fresenius Kabi AG, LLC
2.5.1 Fresenius Kabi AG, LLC Details
2.5.2 Fresenius Kabi AG, LLC Major Business
2.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product and Services
2.5.4 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Scrippslabs
2.6.1 Scrippslabs Details
2.6.2 Scrippslabs Major Business
2.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Product and Services
2.6.4 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Leebio
2.7.1 Leebio Details
2.7.2 Leebio Major Business
2.7.3 Leebio Human Chorionic Gonadotropin (HCG) Product and Services
2.7.4 Leebio Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Kamiya Biomedical Company
2.8.1 Kamiya Biomedical Company Details
2.8.2 Kamiya Biomedical Company Major Business
2.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product and Services
2.8.4 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sanzyme
2.9.1 Sanzyme Details
2.9.2 Sanzyme Major Business
2.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Product and Services
2.9.4 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Cigna
2.10.1 Cigna Details
2.10.2 Cigna Major Business
2.10.3 Cigna Human Chorionic Gonadotropin (HCG) Product and Services
2.10.4 Cigna Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Human Chorionic Gonadotropin (HCG) Sales by Manufacturer
3.1 Global Human Chorionic Gonadotropin (HCG) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Human Chorionic Gonadotropin (HCG)
3.4 Market Concentration Rate
3.4.1 Top 3 Human Chorionic Gonadotropin (HCG) Manufacturer Market Share
3.4.2 Top 6 Human Chorionic Gonadotropin (HCG) Manufacturer Market Share
3.5 Global Human Chorionic Gonadotropin (HCG) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Human Chorionic Gonadotropin (HCG) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Chorionic Gonadotropin (HCG) Market Size by Region
4.1.1 Global Human Chorionic Gonadotropin (HCG) Sales in Volume by Region (2016-2026)
4.1.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2016-2026)
4.2 North America Human Chorionic Gonadotropin (HCG) Revenue (2016-2026)
4.3 Europe Human Chorionic Gonadotropin (HCG) Revenue (2016-2026)
4.4 Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue (2016-2026)
4.5 South America Human Chorionic Gonadotropin (HCG) Revenue (2016-2026)
4.6 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Human Chorionic Gonadotropin (HCG) Sales in Volume by Type (2016-2026)
5.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2016-2026)
5.3 Global Human Chorionic Gonadotropin (HCG) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Human Chorionic Gonadotropin (HCG) Sales in Volume by Application (2016-2026)
6.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2016-2026)
6.3 Global Human Chorionic Gonadotropin (HCG) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2026)
7.2 North America Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2026)
7.3 North America Human Chorionic Gonadotropin (HCG) Market Size by Country
7.3.1 North America Human Chorionic Gonadotropin (HCG) Sales in Volume by Country (2016-2026)
7.3.2 North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2026)
8.2 Europe Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2026)
8.3 Europe Human Chorionic Gonadotropin (HCG) Market Size by Country
8.3.1 Europe Human Chorionic Gonadotropin (HCG) Sales in Volume by Country (2016-2026)
8.3.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2026)
9.2 Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2026)
9.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Size by Region
9.3.1 Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2026)
10.2 South America Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2026)
10.3 South America Human Chorionic Gonadotropin (HCG) Market Size by Country
10.3.1 South America Human Chorionic Gonadotropin (HCG) Sales in Volume by Country (2016-2026)
10.3.2 South America Human Chorionic Gonadotropin (HCG) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2026)
11.2 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2026)
11.3 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Size by Country
11.3.1 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Human Chorionic Gonadotropin (HCG) Typical Distributors
12.3 Human Chorionic Gonadotropin (HCG) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Human Chorionic Gonadotropin (HCG) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Human Chorionic Gonadotropin (HCG) Revenue by Application, (USD Million), 2021-2026
Table 3. EMD Serono, Inc Basic Information, Manufacturing Base and Competitors
Table 4. EMD Serono, Inc Major Business
Table 5. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product and Services
Table 6. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Ferring B.V Basic Information, Manufacturing Base and Competitors
Table 8. Ferring B.V Major Business
Table 9. Ferring B.V Human Chorionic Gonadotropin (HCG) Product and Services
Table 10. Ferring B.V Human Chorionic Gonadotropin (HCG) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 12. Merck & Co., Inc Major Business
Table 13. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product and Services
Table 14. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bristol Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 16. Bristol Myers Squibb Company Major Business
Table 17. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product and Services
Table 18. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Fresenius Kabi AG, LLC Basic Information, Manufacturing Base and Competitors
Table 20. Fresenius Kabi AG, LLC Major Business
Table 21. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product and Services
Table 22. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Scrippslabs Basic Information, Manufacturing Base and Competitors
Table 24. Scrippslabs Major Business
Table 25. Scrippslabs Human Chorionic Gonadotropin (HCG) Product and Services
Table 26. Scrippslabs Human Chorionic Gonadotropin (HCG) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Leebio Basic Information, Manufacturing Base and Competitors
Table 28. Leebio Major Business
Table 29. Leebio Human Chorionic Gonadotropin (HCG) Product and Services
Table 30. Leebio Human Chorionic Gonadotropin (HCG) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Kamiya Biomedical Company Basic Information, Manufacturing Base and Competitors
Table 32. Kamiya Biomedical Company Major Business
Table 33. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product and Services
Table 34. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sanzyme Basic Information, Manufacturing Base and Competitors
Table 36. Sanzyme Major Business
Table 37. Sanzyme Human Chorionic Gonadotropin (HCG) Product and Services
Table 38. Sanzyme Human Chorionic Gonadotropin (HCG) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cigna Basic Information, Manufacturing Base and Competitors
Table 40. Cigna Major Business
Table 41. Cigna Human Chorionic Gonadotropin (HCG) Product and Services
Table 42. Cigna Human Chorionic Gonadotropin (HCG) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Human Chorionic Gonadotropin (HCG), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Human Chorionic Gonadotropin (HCG) Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Human Chorionic Gonadotropin (HCG) Production Site of Key Manufacturer
Table 48. Global Human Chorionic Gonadotropin (HCG) Sales by Region (2016-2021e) & (K Units)
Table 49. Global Human Chorionic Gonadotropin (HCG) Sales by Region (2021-2026) & (K Units)
Table 50. Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2021e) & (K Units)
Table 53. Global Human Chorionic Gonadotropin (HCG) Sales by Type (2021-2026) & (K Units)
Table 54. Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Human Chorionic Gonadotropin (HCG) Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Human Chorionic Gonadotropin (HCG) Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2021e) & (K Units)
Table 59. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2021-2026) & (K Units)
Table 60. Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Human Chorionic Gonadotropin (HCG) Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Human Chorionic Gonadotropin (HCG) Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Human Chorionic Gonadotropin (HCG) Sales by Country (2016-2021e) & (K Units)
Table 65. North America Human Chorionic Gonadotropin (HCG) Sales by Country (2021-2026) & (K Units)
Table 66. North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2021e) & (K Units)
Table 69. North America Human Chorionic Gonadotropin (HCG) Sales by Type (2021-2026) & (K Units)
Table 70. North America Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2021e) & (K Units)
Table 71. North America Human Chorionic Gonadotropin (HCG) Sales by Application (2021-2026) & (K Units)
Table 72. Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2021-2026) & (K Units)
Table 74. Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Human Chorionic Gonadotropin (HCG) Sales by Type (2021-2026) & (K Units)
Table 78. Europe Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Human Chorionic Gonadotropin (HCG) Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales by Application (2021-2026) & (K Units)
Table 88. South America Human Chorionic Gonadotropin (HCG) Sales by Country (2016-2021e) & (K Units)
Table 89. South America Human Chorionic Gonadotropin (HCG) Sales by Country (2021-2026) & (K Units)
Table 90. South America Human Chorionic Gonadotropin (HCG) Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Human Chorionic Gonadotropin (HCG) Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2021e) & (K Units)
Table 93. South America Human Chorionic Gonadotropin (HCG) Sales by Type (2021-2026) & (K Units)
Table 94. South America Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2021e) & (K Units)
Table 95. South America Human Chorionic Gonadotropin (HCG) Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Human Chorionic Gonadotropin (HCG) Typical Distributors
Table 107. Human Chorionic Gonadotropin (HCG) Typical Customers
List of Figures
Figure 1. Human Chorionic Gonadotropin (HCG) Picture
Figure 2. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type in 2020
Figure 3. Natural Source Extraction
Figure 4. Recombinant DNA Technology
Figure 5. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application in 2020
Figure 6. Female Infertility Treatment
Figure 7. Oligospermic Treatment
Figure 8. Cryptorchidism Treatment
Figure 9. Others
Figure 10. Global Human Chorionic Gonadotropin (HCG) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Human Chorionic Gonadotropin (HCG) Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Human Chorionic Gonadotropin (HCG) Sales (2016-2026) & (K Units)
Figure 32. Global Human Chorionic Gonadotropin (HCG) Production Capacity (2016-2026) & (K Units)
Figure 33. Global Human Chorionic Gonadotropin (HCG) Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Human Chorionic Gonadotropin (HCG) Market Drivers
Figure 35. Human Chorionic Gonadotropin (HCG) Market Restraints
Figure 36. Human Chorionic Gonadotropin (HCG) Market Trends
Figure 37. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturer in 2020
Figure 38. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Manufacturer in 2020
Figure 39. Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Human Chorionic Gonadotropin (HCG) Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Human Chorionic Gonadotropin (HCG) Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2016-2026)
Figure 43. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region (2016-2026)
Figure 44. North America Human Chorionic Gonadotropin (HCG) Revenue (2016-2026) & (USD Million)
Figure 45. Europe Human Chorionic Gonadotropin (HCG) Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue (2016-2026) & (USD Million)
Figure 47. South America Human Chorionic Gonadotropin (HCG) Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue (2016-2026) & (USD Million)
Figure 49. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2016-2026)
Figure 50. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2016-2026)
Figure 51. Global Human Chorionic Gonadotropin (HCG) Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2016-2026)
Figure 53. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2016-2026)
Figure 54. Global Human Chorionic Gonadotropin (HCG) Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2016-2026)
Figure 56. North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2016-2026)
Figure 57. North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2016-2026)
Figure 58. North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2016-2026)
Figure 59. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2016-2026)
Figure 60. Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2016-2026)
Figure 61. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2016-2026)
Figure 62. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2016-2026)
Figure 67. South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2016-2026)
Figure 68. South America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2016-2026)
Figure 69. South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2016-2026)
Figure 70. South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のヒト絨毛性ゴナドトロピン市場規模・現状・予測（2021年-2027年） Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta. hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men.…- 世界のヒト絨毛性ゴナドトロピン市場規模・現状・予測（2021年-2027年） Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta. hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men.…
- 世界のヒト絨毛性ゴナドトロピン市場 2021：企業別、地域別、種類・用途別 The Human Chorionic Gonadotropin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の女性不妊症診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Female Infertility Diagnosis and Treatment Market The global Female Infertility Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…
- 世界の女性不妊症診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Female Infertility Diagnosis and Treatment Market The global Female Infertility Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…